H2AFY expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.708400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.969640E-01
Normal-vs-Stage2
7.856000E-01
Normal-vs-Stage3
3.020800E-01
Normal-vs-Stage4
8.613800E-01
Stage1-vs-Stage2
1.552570E-01
Stage1-vs-Stage3
3.910300E-02
Stage1-vs-Stage4
1.633610E-01
Stage2-vs-Stage3
4.473500E-02
Stage2-vs-Stage4
6.121800E-01
Stage3-vs-Stage4
3.476600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.967800E-01
Normal-vs-AfricanAmerican
7.487200E-01
Normal-vs-Asian
5.366400E-01
Caucasian-vs-AfricanAmerican
4.996600E-01
Caucasian-vs-Asian
2.445600E-01
AfricanAmerican-vs-Asian
2.919200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.775800E-01
Normal-vs-Female
7.716600E-01
Male-vs-Female
9.700800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.207400E-01
Normal-vs-Age(41-60Yrs)
3.451000E-01
Normal-vs-Age(61-80Yrs)
9.861400E-01
Normal-vs-Age(81-100Yrs)
6.954800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.509400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.990200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.726200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.158500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.868000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.246200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.672600E-01
Normal-vs-Daily Drinker
8.280800E-01
Normal-vs-Weekly Drinker
8.196800E-01
Normal-vs-Occasional Drinker
4.525800E-01
Normal-vs-Social Drinker
4.843400E-01
Non Drinker-vs-Daily Drinker
9.640000E-01
Non Drinker-vs-Weekly Drinker
4.980800E-01
Non Drinker-vs-Occasional Drinker
4.610400E-01
Non Drinker-vs-Social Drinker
4.101800E-01
Daily Drinker-vs-Weekly Drinker
4.428200E-01
Daily Drinker-vs-Occasional Drinker
4.541800E-01
Daily Drinker-vs-Social Drinker
4.047200E-01
Weekly Drinker-vs-Occasional Drinker
1.213380E-01
Weekly Drinker-vs-Social Drinker
1.372830E-01
Occasional Drinker-vs-Social Drinker
8.388400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.891500E-02
Normal-vs-Grade 2
6.831300E-04
Normal-vs-Grade 3
3.019000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.349370E-01
Grade 1-vs-Grade 3
1.710980E-01
Grade 1-vs-Grade 4
4.891500E-02
Grade 2-vs-Grade 3
8.900400E-01
Grade 2-vs-Grade 4
6.831300E-04
Grade 3-vs-Grade 4
3.019000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.223400E-01
Normal-vs-NonDiabetic
6.380200E-01
Diabetic-vs-NonDiabetic
3.153700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.515800E-01
Normal-vs-NoPancreatitis
8.320200E-01
Pancreatitis-vs-NoPancreatitis
2.401800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.260800E-01
Normal-vs-N1
8.945200E-01
N0-vs-N1
8.314500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.313200E-01
Normal-vs-TP53-NonMutant
7.296200E-01
TP53-Mutant-vs-TP53-NonMutant
8.901400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
